Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...

Key Points Interested in Candel Therapeutics, Inc.? Here are five stocks we like better. Candel Therapeutics said it remains on track to file a BLA by year-end for aglatimagene in localized prostate ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Partnering with University of Michigan Health represents an important step in bringing Unfold AI to leading cancer centers ...

Men given two larger doses of radiation had about the same side effects as others treated with the standard five-dose course, ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine. The results ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

A new experimental drug is showing potential in treating prostate cancer and possibly other forms of the disease. A new immunotherapy drug used in a prostate cancer clinical trial is showing early ...

Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

The 25-year follow-up of the GÖTEBORG-1 trial 5 assessing active surveillance for screen-detected low and intermediate risk ...

A new study has highlighted a significant knowledge gap among patients about repeat radiotherapy (reirradiation) as a treatment option for recurrent prostate cancer ...

Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...